Measles Elimination Status: the U.S. Faces Losing a Designation Held Since 2000, With a Decision Expected Nov. 17
A Pan-American health commission meeting in Washington this week is weighing whether measles has circulated uninterrupted in the United States for more than 12 months. The CDC counted 5,182 confirmed cases this year through Nov. 5 — and no decision has been announced yet.
AUSTIN — The United States is facing the loss of a public-health designation it has held since 2000: measles elimination. A panel convened by the Pan American Health Organization met this week in Washington to consider whether measles transmission has spread uninterrupted in the country for more than 12 months, which is the threshold for losing elimination status. The panel's decision will not be available until Nov. 17, and none has been announced.
Elimination never meant zero cases. It means a country has interrupted continuous, local transmission for at least 12 consecutive months, backed by strong surveillance and laboratory data. A country loses the status when evidence shows the same viral strain has circulated uninterrupted for 12 months or longer. Scientists who analyzed publicly available genetic data from the current outbreaks, in work commissioned by The New York Times, concluded there is strong evidence measles is endemic again — that is the scientists' conclusion from the data, and it is the question the commission is now deciding, not a decision the commission has made.
The case count behind the review is the largest in a generation. The Centers for Disease Control and Prevention reported 5,182 confirmed measles cases in 2026 as of Nov. 5, compared with 2,289 in all of last year — the highest annual total since 1991. Measles was declared eliminated in the United States in 2000, after widespread vaccination nearly wiped out the disease's spread.
For Austin families, what changes on Nov. 17 is a designation, not the guidance: the designation describes the country's transmission record, and regaining it would require interrupting endemic transmission for at least 12 consecutive months and submitting a corrective plan that includes routine immunization coverage of 95 percent or higher. The desk will report the commission's actual decision when it is announced, and claims nothing about it before then.
